JP2013035860A5 - - Google Patents

Download PDF

Info

Publication number
JP2013035860A5
JP2013035860A5 JP2012213895A JP2012213895A JP2013035860A5 JP 2013035860 A5 JP2013035860 A5 JP 2013035860A5 JP 2012213895 A JP2012213895 A JP 2012213895A JP 2012213895 A JP2012213895 A JP 2012213895A JP 2013035860 A5 JP2013035860 A5 JP 2013035860A5
Authority
JP
Japan
Prior art keywords
replenisher
viscous
viscous replenisher
joint
single dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012213895A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013035860A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2013035860A publication Critical patent/JP2013035860A/ja
Publication of JP2013035860A5 publication Critical patent/JP2013035860A5/ja
Pending legal-status Critical Current

Links

JP2012213895A 2004-12-30 2012-09-27 関節内粘性補充のための療法 Pending JP2013035860A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64074904P 2004-12-30 2004-12-30
US60/640,749 2004-12-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007549479A Division JP5725594B2 (ja) 2004-12-30 2005-12-20 関節内粘性補充のための療法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014161991A Division JP2015007077A (ja) 2004-12-30 2014-08-08 関節内粘性補充のための療法

Publications (2)

Publication Number Publication Date
JP2013035860A JP2013035860A (ja) 2013-02-21
JP2013035860A5 true JP2013035860A5 (https=) 2013-12-19

Family

ID=36633154

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2007549479A Expired - Lifetime JP5725594B2 (ja) 2004-12-30 2005-12-20 関節内粘性補充のための療法
JP2012213895A Pending JP2013035860A (ja) 2004-12-30 2012-09-27 関節内粘性補充のための療法
JP2014161991A Pending JP2015007077A (ja) 2004-12-30 2014-08-08 関節内粘性補充のための療法
JP2016010289A Expired - Lifetime JP6139716B2 (ja) 2004-12-30 2016-01-22 関節内粘性補充のための療法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007549479A Expired - Lifetime JP5725594B2 (ja) 2004-12-30 2005-12-20 関節内粘性補充のための療法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014161991A Pending JP2015007077A (ja) 2004-12-30 2014-08-08 関節内粘性補充のための療法
JP2016010289A Expired - Lifetime JP6139716B2 (ja) 2004-12-30 2016-01-22 関節内粘性補充のための療法

Country Status (16)

Country Link
US (4) US7931030B2 (https=)
EP (5) EP1835923B1 (https=)
JP (4) JP5725594B2 (https=)
KR (3) KR101808800B1 (https=)
CN (4) CN102416020A (https=)
AU (1) AU2005323095B2 (https=)
BR (1) BRPI0518542A2 (https=)
CA (2) CA2590159C (https=)
DK (2) DK2664334T3 (https=)
ES (2) ES2537751T3 (https=)
HU (1) HUE025255T2 (https=)
IL (1) IL183581A (https=)
PL (2) PL2664334T3 (https=)
PT (2) PT1835923E (https=)
SI (2) SI2664334T1 (https=)
WO (1) WO2006073835A2 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2891651B2 (ja) 1995-07-03 1999-05-17 三菱重工業株式会社 Ｃ型コイル
US20040081704A1 (en) 1998-02-13 2004-04-29 Centerpulse Biologics Inc. Implantable putty material
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
PT1835923E (pt) 2004-12-30 2013-11-04 Genzyme Corp Regimes para viscossuplementação intra-articular
CA2633978A1 (en) * 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
CA2633957A1 (en) * 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
EP1968498A2 (en) * 2005-12-14 2008-09-17 Anika Therapeutics Inc. Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects
AU2007328871B2 (en) 2006-12-06 2013-11-21 Seikagaku Corporation Pharmaceutical agent having long-lasting effect of treating arthritic disorders
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
ES2658609T3 (es) 2008-09-02 2018-03-12 Tautona Group Lp Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos, y usos de los mismos
MX2012000521A (es) * 2009-07-10 2012-07-17 Milux Holding Sa Dispositivo medico implantable para la lubricacion de una articulacion sinovial y metodo para implantar el dispositivo.
JO3008B1 (ar) 2009-08-13 2016-09-05 Seikagaku Kogyo Co Ltd تركيب صيدلي لتخفيف الألم
JP5824455B2 (ja) 2010-08-23 2015-11-25 デンカ株式会社 架橋ヒアルロン酸組成物及び自己架橋ヒアルロン酸粒子
AU2011329054B2 (en) 2010-11-15 2015-05-28 Zimmer Orthobiologics, Inc. Bone void fillers
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
EP4137139A1 (en) 2013-07-10 2023-02-22 Matrix Biology Institute Compositions of hyaluronan with high elasticity and uses thereof
KR101582380B1 (ko) * 2013-09-11 2016-01-05 주식회사 제네웰 손상 조직에 대한 세포 전달 및 조직 재생용 생체재료와 제조방법
WO2015142781A1 (en) * 2014-03-21 2015-09-24 Rmg, Inc. Mobile based exercise and rehabilitation
GB201408752D0 (en) * 2014-05-16 2014-07-02 Stemmatters Biotecnologia E Medicina Regenerativa Sa Arthritis treatment
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
US10004824B2 (en) 2015-05-11 2018-06-26 Laboratoires Vivacy Compositions comprising at least one polyol and at least one anesthetic
WO2016034745A2 (en) * 2015-09-22 2016-03-10 Cylenchar Limited A method for concentrating and/or entrapping radioisotopes from an aqueous solution
PL3352766T3 (pl) 2015-09-24 2021-08-02 Matrix Biology Institute Kompozycie z hialuronanem o dużej elastyczności i sposoby ich użycia
KR20170090965A (ko) * 2016-01-29 2017-08-08 한미약품 주식회사 복합 히알루론산 가교물 및 그 제조방법
EP3775896B1 (en) * 2018-04-03 2023-06-07 Sanofi Lateral flow immunoassay strip device
WO2022051060A1 (en) * 2020-09-01 2022-03-10 Orthogenrx, Inc. Crosslinking of non-animal-derived hyaluronic acid with divinyl sulfone
WO2025068242A1 (en) * 2023-09-25 2025-04-03 Hyamedix Dexamethasone delivery system

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716224A (en) * 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US4636524A (en) * 1984-12-06 1987-01-13 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US5128326A (en) * 1984-12-06 1992-07-07 Biomatrix, Inc. Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4605691A (en) * 1984-12-06 1986-08-12 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US5099013A (en) 1985-03-12 1992-03-24 Biomatrix, Inc, Hylan preparation and method of recovery thereof from animal tissues
US4713448A (en) 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
SE8501723L (sv) * 1985-04-09 1986-10-10 Pharmacia Ab Preparation att anvendas vid behandling av ledinflammation
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
US4795741A (en) * 1987-05-06 1989-01-03 Biomatrix, Inc. Compositions for therapeutic percutaneous embolization and the use thereof
US5143724A (en) 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
US5246698A (en) 1990-07-09 1993-09-21 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
CA2061566C (en) * 1992-02-20 2002-07-09 Rudolf E. Falk Treatment of disease employing hyaluronic acid and nsaids
US5219360A (en) * 1991-05-10 1993-06-15 Fortis Research Corporation Mammary prosthesis fill and method of making same
US5143351A (en) * 1991-08-29 1992-09-01 Pierce Daniel H Self-locking valve spring retainer
US5690961A (en) * 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
US5612321A (en) * 1995-06-22 1997-03-18 Hercules Incorporated Antioxidant grafted polysaccharides
US5827937A (en) 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
JP3439481B2 (ja) * 1995-11-15 2003-08-25 生化学工業株式会社 光架橋ヒアルロン酸ゲルおよびその製造法
US6096728A (en) * 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
CA2244664C (en) * 1996-02-09 2008-06-03 Amgen Inc. Composition comprising interleukin-1 inhibitor and controlled release polymer
JP3521378B2 (ja) * 1996-08-13 2004-04-19 コニカミノルタホールディングス株式会社 両面複写装置
US6294170B1 (en) * 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
PT939086E (pt) * 1998-02-27 2004-07-30 Stichting Hippomedics Processo para produzir o acido hialuronico reticulado
US6630457B1 (en) * 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
AU774977B2 (en) 1998-11-10 2004-07-15 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid gel, process for the preparation thereof and medical materials containing the same
US6677321B1 (en) * 1999-12-09 2004-01-13 Bruce Levin Methods and compositions for treatment of inflammatory disease
US6521223B1 (en) 2000-02-14 2003-02-18 Genzyme Corporation Single phase gels for the prevention of adhesions
US6645485B2 (en) * 2000-05-10 2003-11-11 Allan R. Dunn Method of treating inflammation in the joints of a body
US6800298B1 (en) * 2000-05-11 2004-10-05 Clemson University Biological lubricant composition and method of applying lubricant composition
US6527760B1 (en) * 2000-09-25 2003-03-04 Vijay B. Vad Out-patient joint lavage kit and protocol
EP1217008B1 (en) * 2000-12-19 2006-03-01 Seikagaku Corporation Photocurable hyaluronic acid derivative and process for producing the same, and photocured crosslinked hyaluronic acid derivative and medical material using the same
US7119062B1 (en) * 2001-02-23 2006-10-10 Neucoll, Inc. Methods and compositions for improved articular surgery using collagen
US20030008817A1 (en) * 2001-07-03 2003-01-09 Tom Sander Cross-link reversing agent
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
CA2477391A1 (en) * 2002-03-01 2003-09-12 Denis Schrier Method of treating osteoarthritis
US20030232784A1 (en) * 2002-06-14 2003-12-18 Benedict James J. Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain
JP4383035B2 (ja) * 2002-10-29 2009-12-16 電気化学工業株式会社 ヒアルロン酸ゲル及びその製造方法
ES2532399T3 (es) * 2003-03-05 2015-03-26 Halozyme, Inc. Glicoproteína hialuronidasa soluble (sHASEGP), proceso para prepararla, usos y composiciones farmacéuticas que la comprenden
US20050026887A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
EP1677806B1 (en) * 2003-10-09 2008-11-19 Robert John Petrella Methods for treating acute and overuse sprain and strain using hyaluronic acid
US8524213B2 (en) * 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
CA2550718C (en) * 2003-12-30 2013-11-05 Genzyme Corporation Cohesive gels from cross-linked hyaluronan and/or hylan, their preparation and use
EP1778360A2 (en) * 2004-07-23 2007-05-02 Mucosal Therapeutics LLC Compositions and methods for viscosupplementation
AU2005272578A1 (en) * 2004-08-13 2006-02-23 Angiotech International Ag Compositions and methods using hyaluronic acid and hyluronidase inhibitors
PT1835923E (pt) 2004-12-30 2013-11-04 Genzyme Corp Regimes para viscossuplementação intra-articular
CA2633957A1 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid

Similar Documents

Publication Publication Date Title
JP2013035860A5 (https=)
Lunn et al. Effect of high-dose preoperative methylprednisolone on pain and recovery after total knee arthroplasty: a randomized, placebo-controlled trial
JP2011515494A5 (https=)
JP6353577B2 (ja) 組み合わせ組成物
JP6673924B2 (ja) 肝機能障害および／または腎機能障害を有する対象における疼痛を治療するためのセブラノパドール
JP2020530857A5 (https=)
JP2015524444A5 (https=)
JP2009524692A5 (https=)
CA2590159A1 (en) Regimens for intra-articular viscosupplementation
BR112015011778A2 (pt) métodos para administrar e avaliar drogas de expulsão de nitrogênio para o tratamento de encefalopatia hepática
JP2015528501A5 (https=)
JP2015522077A5 (https=)
CN1859918A (zh) 使用透明质酸治疗急性和过劳扭伤、拉伤的方法
JP2012525358A5 (https=)
JP2016505050A5 (https=)
BR112012020185A2 (pt) uso de preparações de heparina oral para tratar doenças e afecções do trato urinário.
US20120232031A1 (en) Injectable formulations for intra-articular or peri-articular administration
CN108354898A (zh) 一种治疗类风湿性关节炎的透皮给药制剂及其制备方法
JP2015513554A5 (https=)
FI3359572T3 (fi) Menetelmä multippeliskleroosin hoitamiseksi
CN103181894B (zh) 萘丁美酮喷雾剂及其制备方法
CN110693860B (zh) 一种含酮洛芬的凝胶贴膏及其制备方法
WO2021250204A1 (en) Oral formulation comprising a crystalline form of rabeximod
RU2013105513A (ru) Производные 1-аминоалкилциклогексана для лечения воспалительных заболеваний кожи
VanAtta et al. Guiding osteoarthritis management